A new study published in the journal Progress in Neuro-Psychopharmacology and Biological Psychiatry found that cannabidiol ...

Troculeucel, a cryopreserved, autologous enhanced natural killer cell therapy, has demonstrated preliminary clinical benefit without any drug-related adverse events in two Phase I clinical trials in ...

Melatonin is wildly popular—and wildly misunderstood. Here’s why scientists say taking this supplement doesn’t necessarily ...

Cannabis advocates will hold a mass rally at the Ministry of Public Health on Monday to protest the government's campaign to recriminalise the plant three years after it was removed from the national ...

A consultant explains to the couple that Moth has corticobasal degeneration (CBD), a relatively rare neurological condition in the same family as Parkinson’s disease ... and there is currently no ...

A new weekly Parkinson’s injection may replace daily pills, offering steady symptom control, better compliance, and improved quality of life.

A new treatment for one type of Parkinson's disease may be on the horizon after researchers discovered a "brake" that can halt cell death.

Ambroxol, a common cough syrup, may slow Parkinson's dementia, offering hope for patients and families, according to a recent clinical trial.

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care ...

Putting the brakes on an enzyme might rescue neurons that are dying due to a type of Parkinson's disease that's caused by a single genetic mutation, according to a new Stanford Medicine-led study ...